Pfizer is bringing more new drugs to China, Yang Ying, VP of the US pharma giant's Worldwide Business Development Asia Lead, told Yicai Global at CIIE. These include the world’s only therapy for ATTR cardiomyopathy and a ADC-based drug for acute lymphoblastic leukemia.